Immatics (IMTX) Stock Chart & Stock Price History $3.50 -0.34 (-8.85%) Closing price 04:00 PM EasternExtended Trading$3.50 +0.00 (+0.14%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immatics Stock Price Performance 5 Day Performance-24.41%1 Month Performance-19.35%3 Month Performance-51.19%6 Month Performance-67.77%Year-To-Date Performance-50.77%1 Year Performance-67.32% Receive IMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter. Email Address IMTX Stock Chart for Friday, April, 4, 2025 IMTX Chart by TradingViewRemove Ads Immatics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$3.84$3.50-8.85%$3.86$3.391.53 million shs$417.75 million04/03/2025$4.17$3.84-7.91%$4.26$3.83736,637 shs$458.33 million04/02/2025$4.00$4.17+4.25%$4.25$3.88755,575 shs$497.72 million04/01/2025$4.51$4.00-11.31%$4.44$3.882.07 million shs$477.42 million03/31/2025$4.63$4.51-2.59%$4.58$4.35494,837 shs$538.30 million03/28/2025$4.71$4.63-1.70%$4.98$4.55574,428 shs$552.62 million03/27/2025$4.53$4.71+3.97%$5.21$4.64836,333 shs$562.17 million03/26/2025$4.68$4.53-3.21%$4.68$4.462.60 million shs$540.68 million03/25/2025$5.00$4.68-6.40%$5.11$4.68314,272 shs$558.59 million03/24/2025$5.00$5.00$5.18$4.93357,962 shs$596.78 million Get the Latest News and Ratings for IMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$5.30$5.00-5.66%$5.32$4.86516,803 shs$596.78 million03/20/2025$5.37$5.30-1.30%$5.63$5.202.12 million shs$632.59 million03/19/2025$5.11$5.37+5.09%$5.38$4.86793,799 shs$640.94 million03/18/2025$4.98$5.11+2.61%$5.14$4.87627,237 shs$609.91 million03/17/2025$4.55$4.98+9.45%$5.01$4.58681,108 shs$594.39 million03/14/2025$4.52$4.55+0.66%$4.62$4.46393,358 shs$543.07 million03/13/2025$4.55$4.52-0.66%$4.63$4.39442,796 shs$539.49 million03/12/2025$4.45$4.55+2.25%$4.62$4.43198,780 shs$543.07 million03/11/2025$4.50$4.45-1.11%$4.53$4.37469,271 shs$531.13 million03/10/2025$4.66$4.50-3.43%$4.65$4.43333,010 shs$537.10 million03/07/2025$4.80$4.66-2.92%$4.80$4.62233,848 shs$556.20 million03/06/2025$4.80$4.80$4.82$4.64337,462 shs$572.91 million03/05/2025$4.34$4.80+10.60%$4.81$4.37918,249 shs$572.91 million03/04/2025$4.18$4.34+3.83%$4.39$4.06681,280 shs$518.01 million03/03/2025$4.38$4.18-4.57%$4.41$4.18400,485 shs$498.91 million Related Companies Mirum Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Edgewise Therapeutics Stock Chart Centessa Pharmaceuticals Stock Chart Kymera Therapeutics Stock Chart CG Oncology Stock Chart Denali Therapeutics Stock Chart Belite Bio Stock Chart Arrowhead Pharmaceuticals Stock Chart Arcutis Biotherapeutics Stock Chart Receive IMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMTX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. Share Immatics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
